The in Monrovia, California, has announced seventy-nine grants totaling more than $22 million in support of childhood cancer research.
Grant recipients include the , which was awarded a five-year "consortium" grant in support of the , which will use the grant to evaluate the clinical utility of real-time sharing and integration of pediatric cancer data generated by genomic studies in the U.S. and Canada. Using data on ten thousand tumors from previous research, the initiative will compare an individual child's cancer to both childhood and adult patient cohorts across all cancer types to assist decision making for treatments. It is hoped the cross-cancer analysis can help clinicians identify cases where a drug developed for another indication may work in a pediatric cancer, providing new treatment options for children with cancer.
Other grant recipients include the , , , , , and the .
"At St. Baldrick's, we believe that every child deserves to live a happy and healthy life, free from cancer," said the foundation’s CEO, Kathleen Ruddy. "Although progress has been made, there is still much to be done when it comes to finding cures for the countless subtypes of kids' cancers and creating less-toxic treatments. Kids are special and need to be treated that way. Our donors, volunteers, and partners make these grants possible, and we are beyond thankful for each and every one of our supporters for contributing to our mission."
For a complete list of grant , see the St. Baldrick's Foundation website.